Login / Signup

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.

Oriana NanniPierluigi VialeBernadette VertogenClaudia LilliChiara ZingarettiCaterina DonatiCarla MasiniManuela MontiPatrizia SerraRoberto VespignaniVeruska GrossiAnnibale BiggeriEmanuela ScarpiFrancesca GalardiLucia BertoniAmerico ColamartiniFabio FalciniMattia AltiniIlaria MassaRaffaella GaggeriGiovanni Martinelli
Published in: Trials (2020)
The full PROTECT protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interests of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol (Protocol final version, 15th April 2020). The study protocol has been reported in accordance with Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines (Additional file 2).
Keyphrases
  • coronavirus disease
  • randomized controlled trial
  • study protocol
  • clinical trial
  • sars cov
  • phase ii
  • double blind
  • combination therapy